# Iovance Biotherapeutics, Inc.: filings

IOVA · Nasdaq · CIK 1425205 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/iova.md) · [Financials](/companies/iova/financials.md) · [Filings](/companies/iova/filings.md) · [Insiders](/companies/iova/insiders.md)

## Reports and events: 372 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 295, 8-K 248, 10-Q 53, SC 13G/A 51, 3 43, SC 13G 27, UPLOAD 25, 424B5 21, CORRESP 21, EFFECT 21, S-8 20, 10-K 18, 8-K/A 14, DEF 14A 14, DEFA14A 14, POS AM 11, CT ORDER 10, SC 13D/A 10, 424B3 9, S-3 9, D 8, NT 10-Q 8, S-3/A 6, PRE 14A 5, 4/A 4, 5 4, ARS 4, S-1/A 4, SC 13D 4, SCHEDULE 13G/A 4, 10-K/A 3, 144 3, NT 10-K 3, S-3ASR 3, S-8 POS 3, 10-Q/A 2, PRER14A 2, S-1 2, S-3MEF 2, SC 14F1 2, 3/A 1, 8-A12B 1, 8-A12B/A 1, CERTNAS 1, DEF 14C 1, PRE 14C 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 17:00 ET | [8-K](/filings/0001104659-26-120261.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-120261 |
| 2026-10-05 | 17:00 ET | [8-K](/filings/0001104659-26-113763.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-113763 |
| 2026-09-29 | 07:05 ET | [8-K](/filings/0001104659-26-111583.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-111583 |
| 2026-08-06 | 17:30 ET | [8-K](/filings/0001104659-26-092145.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-092145 |
| 2026-08-06 | 09:15 ET | [10-Q](/filings/0001104659-26-091716.md) | Quarterly report, period 2026-06-30 | 0001104659-26-091716 |
| 2026-08-06 | 07:05 ET | [8-K](/filings/0001104659-26-091619.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-091619 |
| 2026-07-02 | 17:01 ET | [8-K](/filings/0001104659-26-080409.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-080409 |
| 2026-06-10 | 17:01 ET | [8-K](/filings/0001104659-26-072408.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-072408 |
| 2026-05-07 | 09:18 ET | [8-K](/filings/0001104659-26-056782.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-056782 |
| 2026-05-07 | 09:16 ET | [10-Q](/filings/0001104659-26-056778.md) | Quarterly report, period 2026-03-31 | 0001104659-26-056778 |
| 2026-04-28 | 17:01 ET | [DEF 14A](/filings/0001104659-26-050458.md) | Proxy statement, period 2026-06-10 | 0001104659-26-050458 |
| 2026-03-20 | 17:00 ET | [8-K](/filings/0001104659-26-032774.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-032774 |
| 2026-02-24 | 09:35 ET | [10-K](/filings/0001104659-26-018899.md) | Annual report, period 2025-12-31 | 0001104659-26-018899 |
| 2026-02-24 | 08:00 ET | [8-K](/filings/0001104659-26-018837.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-018837 |
| 2026-01-09 | 07:35 ET | [8-K](/filings/0001104659-26-002323.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-002323 |
| 2025-11-06 | 09:15 ET | [10-Q](/filings/0001104659-25-107470.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107470 |
| 2025-11-06 | 08:05 ET | [8-K](/filings/0001104659-25-107426.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107426 |
| 2025-08-29 | 16:06 ET | [8-K](/filings/0001104659-25-085650.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-085650 |
| 2025-08-22 | 17:18 ET | [8-K](/filings/0001104659-25-081953.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-081953 |
| 2025-08-19 | 16:47 ET | [8-K](/filings/0001104659-25-080304.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-080304 |
| 2025-08-07 | 17:16 ET | [10-Q](/filings/0001558370-25-010807.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010807 |
| 2025-08-07 | 16:06 ET | [8-K](/filings/0001104659-25-075175.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-075175 |
| 2025-07-15 | 07:36 ET | [8-K](/filings/0001104659-25-067940.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-067940 |
| 2025-07-03 | 16:05 ET | [8-K](/filings/0001104659-25-065781.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-065781 |
| 2025-06-13 | 17:15 ET | [8-K](/filings/0001104659-25-059464.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-059464 |
| 2025-06-10 | 17:15 ET | [8-K](/filings/0001104659-25-058199.md) | 5.07 Shareholder vote results | 0001104659-25-058199 |
| 2025-05-08 | 17:15 ET | [10-Q](/filings/0001558370-25-007009.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007009 |
| 2025-05-08 | 16:05 ET | [8-K](/filings/0001104659-25-046101.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-046101 |
| 2025-04-28 | 17:00 ET | [DEF 14A](/filings/0001558370-25-005702.md) | Proxy statement, period 2025-06-10 | 0001558370-25-005702 |
| 2025-02-27 | 17:15 ET | [10-K](/filings/0001558370-25-001834.md) | Annual report, period 2024-12-31 | 0001558370-25-001834 |
| 2025-02-27 | 16:05 ET | [8-K](/filings/0001104659-25-018212.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-018212 |
| 2025-02-10 | 07:22 ET | [8-K](/filings/0001104659-25-010729.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-010729 |
| 2024-11-21 | 17:15 ET | [8-K](/filings/0001104659-24-121612.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001104659-24-121612 |
| 2024-11-08 | 21:03 ET | [8-K](/filings/0001104659-24-115444.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-115444 |
| 2024-11-07 | 17:15 ET | [10-Q](/filings/0001558370-24-014905.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014905 |
| 2024-11-07 | 16:06 ET | [8-K](/filings/0001104659-24-115300.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-115300 |
| 2024-08-09 | 17:16 ET | [8-K](/filings/0001104659-24-087876.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-087876 |
| 2024-08-08 | 17:10 ET | [10-Q](/filings/0001558370-24-011641.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011641 |
| 2024-08-08 | 16:05 ET | [8-K](/filings/0001104659-24-087259.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-087259 |
| 2024-06-28 | 07:30 ET | [8-K](/filings/0001104659-24-075997.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-075997 |
| 2024-06-11 | 17:15 ET | [8-K](/filings/0001104659-24-070470.md) | 5.07 Shareholder vote results | 0001104659-24-070470 |
| 2024-06-03 | 08:01 ET | [8-K](/filings/0001104659-24-067485.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-067485 |
| 2024-05-24 | 20:00 ET | [8-K](/filings/0001104659-24-064825.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-064825 |
| 2024-05-09 | 17:10 ET | [10-Q](/filings/0001558370-24-007646.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007646 |
| 2024-05-09 | 16:06 ET | [8-K](/filings/0001104659-24-059322.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-059322 |
| 2024-04-29 | 17:06 ET | [DEF 14A](/filings/0001558370-24-006148.md) | Proxy statement, period 2024-06-11 | 0001558370-24-006148 |
| 2024-04-03 | 17:15 ET | [8-K](/filings/0001104659-24-043158.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-043158 |
| 2024-03-29 | 17:00 ET | [8-K](/filings/0001104659-24-041200.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-24-041200 |
| 2024-03-19 | 17:19 ET | [SC 13D/A](/filings/0001104659-24-036221.md) | Ownership report, active investor, amended | 0001104659-24-036221 |
| 2024-03-04 | 08:00 ET | [8-K](/filings/0001104659-24-030249.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-030249 |

Page 1 of 8. [Older](/companies/iova/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:02 ET. No prices; not investment advice.